Submit Paper

Article Processing Fee

Pay Online

           

Crossref logo

  DOI Prefix   10.20431


 

ARC Journal of Pharmaceutical Sciences
Volume 5, Issue 1, 2019, Page No: 1-4

Polypharmacy in Clinical Practice

Shalini Gupta

University of Dundee Nethergate Dundee Scotland, UK.

Citation : Shalini Gupta, Phytochemical Screening, Polypharmacy in Clinical Practice ARC Journal of Pharmaceutical Sciences 2019, 5(1) : 1-4.

Introduction

Pharmacotherapy is undoubtedly the most common clinical intervention for many disease conditions. While it can be highly effective in treating diseases or slowing disease progression, there are often concerns raised regarding the inappropriate use of drugs. This can lead to adverse drug reactions (ADR) and drug-drug interactions (DDI). The term polypharmacy means "multiple medications" and is considered to be present when a patient takes five or more medications. It may be "appropriate polypharmacy" when all drugs are prescribed for specific therapeutic objectives and the drug therapy has been optimised to minimise the risk of ADR. However, on occasions "inappropriate polypharmacy" might be present, when one or more drugs are prescribed that are no longer needed, and the combination of several drugs puts the patient at an unacceptably high risk of ADR.


Download Full paper: Click Here